New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Certain gene signaling rewires tumors after immunotherapy

Certain gene signaling rewires tumors after immunotherapy

by Anna Megdell,University of MichiganGraphical abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2022.12.008Researchers from the University of Michigan Rogel Cancer Center ha
Oncology January 02,2024
Certain gene signaling rewires tumors after immunotherapy

Certain gene signaling rewires tumors after immunotherapy

by Anna Megdell,University of MichiganGraphical abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2022.12.008Researchers from the University of Michigan Rogel Cancer Center ha
Oncology January 02,2024
Merck, Moderna detail potential skin cancer vaccine progress

Merck, Moderna detail potential skin cancer vaccine progress

by Tom MurphyA sign marks an entrance to a Moderna building in Cambridge, Mass., on Monday, May 18, 2020. Shares of Merck and Moderna jumped early Tuesday, Dec. 13, 2022, after the drugmakers said a p
Oncology January 02,2024
Merck, Moderna detail potential skin cancer vaccine progress

Merck, Moderna detail potential skin cancer vaccine progress

by Tom MurphyA sign marks an entrance to a Moderna building in Cambridge, Mass., on Monday, May 18, 2020. Shares of Merck and Moderna jumped early Tuesday, Dec. 13, 2022, after the drugmakers said a p
Oncology January 02,2024
US residents of Mexican descent may have a higher risk of liver cancer with each successive generation

US residents of Mexican descent may have a higher risk of liver cancer with each successive generation

byAmerican Association for Cancer ResearchCredit: CC0 Public DomainThe risk of hepatocellular carcinoma (HCC) in individuals of Mexican descent living in Los Angeles has increased with each succ
Oncology January 02,2024
US residents of Mexican descent may have a higher risk of liver cancer with each successive generation

US residents of Mexican descent may have a higher risk of liver cancer with each successive generation

byAmerican Association for Cancer ResearchCredit: CC0 Public DomainThe risk of hepatocellular carcinoma (HCC) in individuals of Mexican descent living in Los Angeles has increased with each succ
Oncology January 02,2024
Modeling the use of beta radiation in cancer treatment

Modeling the use of beta radiation in cancer treatment

bySpringerIllustration of beta decay proceeding against the backdrop of a Monte Carlo simulation. Credit: Robert LeaTreating superficial skin tumors especially when they are located above cartil
Oncology January 02,2024
Modeling the use of beta radiation in cancer treatment

Modeling the use of beta radiation in cancer treatment

bySpringerIllustration of beta decay proceeding against the backdrop of a Monte Carlo simulation. Credit: Robert LeaTreating superficial skin tumors especially when they are located above cartil
Oncology January 02,2024
Cancer patients facing housing instability show greater risk of mortality

Cancer patients facing housing instability show greater risk of mortality

byUniversity of California - San DiegoThe study was led by Matthew P. Banegas, PhD, an associate professor at UC San Diego School of Medicine and co-director of the Center for Health Equity Educ
Oncology January 02,2024
Cancer patients facing housing instability show greater risk of mortality

Cancer patients facing housing instability show greater risk of mortality

byUniversity of California - San DiegoThe study was led by Matthew P. Banegas, PhD, an associate professor at UC San Diego School of Medicine and co-director of the Center for Health Equity Educ
Oncology January 02,2024
Clinical trial generates promising results for immunotherapy drug nivolumab in patients with advanced skin cancer

Clinical trial generates promising results for immunotherapy drug nivolumab in patients with advanced skin cancer

byWileyCredit: CC0 Public DomainNumerous studies have shown that drugs called immune checkpoint inhibitors can boost the immune system's response against various cancers. Now a phase II clin
Oncology January 02,2024
Clinical trial generates promising results for immunotherapy drug nivolumab in patients with advanced skin cancer

Clinical trial generates promising results for immunotherapy drug nivolumab in patients with advanced skin cancer

byWileyCredit: CC0 Public DomainNumerous studies have shown that drugs called immune checkpoint inhibitors can boost the immune system's response against various cancers. Now a phase II clin
Oncology January 02,2024
Molecular change to immunotherapy antibody could accelerate immune response to cancer

Molecular change to immunotherapy antibody could accelerate immune response to cancer

byWeizmann Institute of ScienceTissue sample of a particularly aggressive skin cancer reveals immune cells (yellow) that express on their surfaces a “brake pedal” receptor called FcgIIb (purple)
Oncology January 02,2024
Molecular change to immunotherapy antibody could accelerate immune response to cancer

Molecular change to immunotherapy antibody could accelerate immune response to cancer

byWeizmann Institute of ScienceTissue sample of a particularly aggressive skin cancer reveals immune cells (yellow) that express on their surfaces a “brake pedal” receptor called FcgIIb (purple)
Oncology January 02,2024
How immune cells detect and respond to mutations in cancer cells

How immune cells detect and respond to mutations in cancer cells

byUniversity of California, Los AngelesScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDFor the first time, a r
Oncology January 02,2024
How immune cells detect and respond to mutations in cancer cells

How immune cells detect and respond to mutations in cancer cells

byUniversity of California, Los AngelesScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDFor the first time, a r
Oncology January 02,2024
Reprogramming of immune cells shown to fight off melanoma

Reprogramming of immune cells shown to fight off melanoma

byUniversity of BristolmiR223 inhibition reduces cancer progression in zebrafish. A) Pigmentation of the tailfin quantified by threshold analysis of tail region (red dotted outline) in 1-month-o
Oncology January 02,2024
Reprogramming of immune cells shown to fight off melanoma

Reprogramming of immune cells shown to fight off melanoma

byUniversity of BristolmiR223 inhibition reduces cancer progression in zebrafish. A) Pigmentation of the tailfin quantified by threshold analysis of tail region (red dotted outline) in 1-month-o
Oncology January 02,2024
Immune system holds clues to patients with high-risk smoldering myeloma likely to benefit from treatment

Immune system holds clues to patients with high-risk smoldering myeloma likely to benefit from treatment

byDana-Farber Cancer InstituteGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.10.017For many patients with a condition that often precedes multiple myeloma, e
Oncology January 02,2024
Immune system holds clues to patients with high-risk smoldering myeloma likely to benefit from treatment

Immune system holds clues to patients with high-risk smoldering myeloma likely to benefit from treatment

byDana-Farber Cancer InstituteGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.10.017For many patients with a condition that often precedes multiple myeloma, e
Oncology January 02,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com